Chen Wei was born in Lanxi, a county-level city in Jinhua, East China's Zhejiang province, in February 1966. She is a member of the Communist Party of China as well as director and researcher at the Institute of Military Medicine under the Academy of Military Sciences. She is a long-time researcher of biohazard prevention and control.
Currently, she is aiding in efforts to overcome the epidemic. Her team has created a COVID-19 vaccine and pushed forward clinical trials.
Chen was awarded the "People's Hero" national honorary title at a meeting commending role models in China's fight against the COVID-19 epidemic on Sept 8.
On March 16, the subunit vaccine against COVID-19 created by Chen's team was approved for clinical trials.
On April 10, the potential vaccine for COVID-19 appeared safe and able to generate an immune response after phase-1 clinical trials including 108 volunteers.
On April 12, the second phase of clinical trials started. It was the only COVID-19 vaccine in the world that had entered second-phase clinical trials at that time. The experimental results have been published on The Lancet, an international academic journal.
On Aug 11, the vaccine was granted a national patent. It became the first COVID-19 vaccine to start clinical trials and obtain patent rights in China.
On Sept 7, Chen said that the recombinant vaccine developed by her team is effective against all mutations of the novel coronavirus. China can currently produce 300 million doses of the recombinant COVID-19 vaccine per year and will further expand its capacity.
On Feb 26, Chen's birthday, the first batch of vaccine developed by her team went on production line.
收到领导和朋友们给她发的祝福，陈薇当时回复了8个字：“除了胜利，别无选择！（No choice but success）”